Posts Tagged ‘state importation programs’
Canadian Drug Importation Stalls
The White House approved regulations for state drug importation in late state, green-lighting several states’ efforts to implement importation.
None of them is up and running yet. Check out this week’s video and post for an update.
[...]HHS Secretary Sent Congress The Certification To Allow Canadian Drug Importation
On September 23, 2020, Department of Health and Human Services Alex Azar submitted a letter to House Minority Leader Kevin McCarthy certifying that Canadian drug importation would pose not additional threats to consumers and would save Americans a significant amount of money on prescription drugs.
[...]Trump Administration Defies 20 Years of FDA Expertise and Guidance in Finalizing Politically Motivated Drug Importation Rule
Trump Administration Defies 20 Years of FDA Expertise and Guidance in Finalizing Politically Motivated Drug Importation Rule Washington, D.C. (September 24, 2020) – Shabbir Safdar, executive director of the Partnership for Safe Medicines, released the following statement in response to the Trump Administration’s Final Rule issued today on the importation of prescription drugs: “With 40…
[...]Final regulations released governing Canadian drug importation
On September 24th, 2020 the U.S. Department of Health and Human Services released a draft of finalized rulemaking for Importation of Prescription Drugs. Watch this space for the most up-to-date news.
[...]Delaware Legislative Group Says Importation only “seems good until one understands the details.”
In January, the Delaware’s Interagency Pharmaceuticals Purchasing Study Group opined that that importation was not a viable strategy to lower prescription drug prices.
[...]Canadian health law experts predict: Canada won’t end up as the drugstore to the U.S.
This editorial by David C. Rosenbaum and Dara Jospé was published in the Financial Post on January 16, 2020. Rosenbaum is a partner of the law firm Fasken. Jospé is an associate for the same company.
[...]Academic Warns That State Drug Importation Proposals Threaten Patients and Innovation
This editorial by Dr. Kristina M. L. Acri née Lybecker was published in IP Watchdog on January 2, 2020. Dr. Acri is an Associate Professor of Economics at Colorado College in Colorado Springs, and Chair of the Department of Economics and Business.
[...]